Patents by Inventor Connie M. Drysdale

Connie M. Drysdale has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Association of &bgr;2-adrenergic receptor haplotypes with drug response
    Patent number: 6586183
    Abstract: Genotypes and haplotypes for thirteen polymorphic sites in the &bgr;2-adrenergic receptor (&bgr;2AR) gene are disclosed. Compositions and methods for predicting genetic predisposition to disease associated with polymorphic sites in the (&bgr;2AR) gene, as well as for predicting response to &bgr;-agonists, are also disclosed.
    Type: Grant
    Filed: March 16, 2001
    Date of Patent: July 1, 2003
    Assignee: Genaissance Pharmaceuticals, Inc.
    Inventors: Connie M. Drysdale, Richard S. Judson, Stephen B. Liggett, Krishnan Nandabalan, Catherine B. Stack, J. Claiborne Stephens
  • Association of beta2-adrenergic receptor haplotypes with drug response
    Publication number: 20030091998
    Abstract: Genotypes and haplotypes for thirteen polymorphic sites in the &bgr;2-adrenergic receptor (&bgr;2AR) gene are disclosed. Compositions and methods for predicting genetic predisposition to disease associated with polymorphic sites in the (&bgr;2AR) gene, as well as for predicting response to &bgr;-agonists, are also disclosed.
    Type: Application
    Filed: March 16, 2001
    Publication date: May 15, 2003
    Inventors: Connie M. Drysdale, Richard S. Judson, Stephen B. Liggett, Krishnan Nandabalan, J. Claiborne Stephens
  • Association of beta2-adrenergic receptor haplotypes with drug response
    Publication number: 20030039979
    Abstract: Genotypes and haplotypes for thirteen polymorphic sites in the &bgr;2-adrenergic receptor (&bgr;2AR) gene are disclosed. Compositions and methods for predicting genetic predisposition to disease associated with polymorphic sites in the (&bgr;2AR) gene, as well as for predicting response to &bgr;-agonists, are also disclosed.
    Type: Application
    Filed: September 12, 2001
    Publication date: February 27, 2003
    Inventors: Stephen B. Liggett, Connie M. Drysdale, J. Claiborne Stephens, Krishnan Nandabalan, Richard S. Judson, Catherine M. Stack
  • Association of beta2-adrenergic receptor haplotypes with drug response
    Publication number: 20010051712
    Abstract: Genotypes and haplotypes for thirteen polymorphic sites in the &bgr;2-adrenergic receptor (&bgr;2AR) gene are disclosed. Compositions and methods for predicting genetic predisposition to disease associated with polymorphic sites in the (&bgr;2AR) gene, as well as for predicting response to &bgr;-agonists, are also disclosed.
    Type: Application
    Filed: March 16, 2001
    Publication date: December 13, 2001
    Inventors: Connie M. Drysdale, Richard S. Judson, Stephen B. Liggett, Krishnan Nandabalan, Catherine B. Stack, J. Claiborne Stephens